Columbia Research Enhanced Value ETF (REVS) Short Interest Ratio & Short Volume

Short interest is the volume of Columbia Research Enhanced Value ETF shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 6,200 shares of REVS short. Learn More on Columbia Research Enhanced Value ETF's current short interest.

Columbia Research Enhanced Value ETF saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 6,200 shares, a decrease of 40.4% from the previous total of 10,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Columbia Research Enhanced Value ETF: Simplify US Equity PLUS Convexity ETF (0.07%), AllianzIM U.S. Large Cap Buffer10 Jul ETF (0.55%), Virtus Terranova U.S. Quality Momentum ETF (1.09%), Bancreek US Large Cap ETF (0.03%), SGI U.S. Large Cap Core ETF (0.04%), First Trust Multi-Manager Large Growth ETF (0.01%), Simplify US Equity PLUS Downside Convexity ETF (0.01%), Putnam Focused Large Cap Growth ETF (0.06%), Direxion Daily Magnificent 7 Bull 2X Shares (0.69%), Xtrackers Russell 1000 US QARP ETF (2.83%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling REVS is an investing strategy that aims to generate trading profit from Columbia Research Enhanced Value ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Columbia Research Enhanced Value ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REVS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVS, twice per month. The most recent reporting period available is May, 15 2025.